Telix Pharmaceuticals Ltd has released a press release.
Investor Presentation
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Telix announces completion of $40.0 million Placement
- Telix Reports Positive Phase III Meeting with the FDA
- Telix and Monrol Manufacturing and Distribution Agreement
- Telix and Osaka University Extend Collaboration
- Prostate Imaging Program - Commercial and Regulatory Update
Later from Telix Pharmaceuticals
- Telix Receives $9.3m R&D Tax Refund
- Appendix 4C - June 2019 Quarter
- Sales Note to Accompany June 2019 Quarter Appendix 4C
- Telix and Merck Group Combination Therapy Collaboration
- Telix and GenesisCare Commence Prostate Cancer Study
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals